Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 6Not yet recruiting 6Completed 2Active not recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Neoplasm Metastasis 2Solid Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1Pancreatic Cancer Non-resectable 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Neuroblastoma 1Colorectal Neoplasms 1Borderline Resectable Pancreatic Cancer 1Biliary Tract Neoplasms 1Advanced Esophageal Squamous Cell Cancer 1

Interventions

Fluorouracil 80Oxaliplatin 72Leucovorin 66Irinotecan 61Capecitabine 58Bevacizumab 57Cetuximab 43Folfox protocol 22Drug Therapy 22Neoadjuvant Therapy 19HMPL-013 17Colonoscopy 17regorafenib 15apatinib 11Panitumumab 11Chemotherapy, Adjuvant 11trifluridine tipiracil drug combination 10XELOX 10Laparoscopy 10IFL protocol 10sintilimab 9raltitrexed 9Radiotherapy 9Blood Specimen Collection 9Surveys and Questionnaires 8Surgical Procedures, Operative 8tislelizumab 7pembrolizumab 7Endoscopic Mucosal Resection 7Aspirin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colorectal Neoplasms × irinotecan sucrosofate × Clear all
NCT06225622 2024-03-19

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

Shanghai Zhongshan Hospital

Phase 1 Unknown
78 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡